PharmaCyte Biotech (PMCB) Intangibles (2013 - 2026)
PharmaCyte Biotech's Intangibles was $1.55 million in fiscal Q3 2026 (quarter ended Jan 31, 2026), unchanged from $1.55 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Intangibles (2013 - 2026) Analysis & Trends
From fiscal Q2 2014 onward, PharmaCyte Biotech has reported Intangibles for 50 quarters.
- Intangibles shows a five-year compound annual growth rate of -15.3% (FY2020 to FY2025).
- In earlier fiscal years, Intangibles was $1.55 million in FY2024 (-56.3%), $3.55 million in FY2023 (unchanged), $3.55 million in FY2022 (unchanged) and $3.55 million in FY2021 (unchanged).
- Quarterly Intangibles has moved between $1.55 million (fiscal Q4 2024) and $3.55 million (fiscal Q3 2024) over five years.
- Across the past five years, year-over-year decline in Intangibles ran from 0.0% in fiscal Q3 2026 to 56.3% in fiscal Q4 2024.
- Per Business Quant data, PMCB's Intangibles in the three fiscal quarters before Q3 2026 was $1.55 million (Q2 2026), $1.55 million (Q1 2026) and $1.55 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2026 | 1.55 Mn |
| Oct 31, 2025 | 1.55 Mn |
| Jul 31, 2025 | 1.55 Mn |
| Apr 30, 2025 | 1.55 Mn |
| Jan 31, 2025 | 1.55 Mn |
| Oct 31, 2024 | 1.55 Mn |
| Jul 31, 2024 | 1.55 Mn |
| Apr 30, 2024 | 1.55 Mn |
| Jan 31, 2024 | 3.55 Mn |
| Oct 31, 2023 | 3.55 Mn |
| Jul 31, 2023 | 3.55 Mn |
| Apr 30, 2023 | 3.55 Mn |
| Jan 31, 2023 | 3.55 Mn |
| Oct 31, 2022 | 3.55 Mn |
| Jul 31, 2022 | 3.55 Mn |
| Apr 30, 2022 | 3.55 Mn |
| Jan 31, 2022 | 3.55 Mn |
| Oct 31, 2021 | 3.55 Mn |
| Jul 31, 2021 | 3.55 Mn |
| Apr 30, 2021 | 3.55 Mn |
API Access
PharmaCyte Biotech Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();